Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
BackgroundTo investigate the value of serum adropin in predicting chronic kidney disease (CKD) progression in subjects with type 2 diabetes (T2D).Materials and methodsSerum adropin levels were measured in normal control and T2D patients with various stage of CKD. CKD progression was defined as ≥ 30%...
Saved in:
Main Authors: | I-Wen Chen, Cheng-Wei Lin, Chia-Ni Lin, Szu-Tah Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1511730/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease
by: Wei Qin, et al.
Published: (2025-02-01) -
Finerenone in the management of diabetes kidney disease
by: Parijat De, et al.
Published: (2025-02-01) -
Clinical advances in kidney autotransplantation: a review
by: Shengjie Lin, et al.
Published: (2025-02-01) -
RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease
by: Zhaochen Guo, et al.
Published: (2025-02-01) -
New insights into the mechanism of triphenyl phosphate and its metabolite diphenyl phosphate in diabetic kidney disease
by: Ting Fang, et al.
Published: (2025-02-01)